Skip to main content
SpringerLink
Log in

Brustkrebsprävention mit Tamoxifen

Die IBIS-I-Studie

  • Journal Club
  • Published:
Gynäkologische Endokrinologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Cuzick J (2001) A brief review of the current breast cancer prevention trials and proposals for future trials. Eur J Cancer 36:1298–1302

    Article  Google Scholar 

  2. Early Breast Cancer Trialists‘ Collobarative Group (1998) Tamoxifen for early breast cancer: an overview of randomiced trials. Lancet 351:1451–1467

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Münster, Münster

    K. Rensing & L. Kiesel

  2. Klinik und Poliklinik für Gynäkologie und Geburtshilfe, UKM Münster, 48129, Münster

    K. Rensing

Authors
  1. K. Rensing
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Kiesel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. Rensing.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rensing, K., Kiesel, L. Brustkrebsprävention mit Tamoxifen. Gynäkologische Endokrinologie 1, 200–202 (2003). https://doi.org/10.1007/s10304-003-0033-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10304-003-0033-6

Search

Navigation